InsiderDB
Sign inStart free trial

Rep. Daniel S. Goldman sold Novo Nordisk A/S (NVO)

Rep. Daniel S. Goldman (D-NY-10) · $250K–$500K · traded Jul 10, 2023

Transaction
Sold
Amount
$250K–$500K
Owner
Not stated
Traded
Jul 10, 2023
Disclosed
Aug 13, 2023
Days to disclose
34
Asset type
Stock
As filed
Novo Nordisk A/S
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Goldman's tradesAll Congress trades in NVO

Other trades in this filing

All of Goldman's trades →

Recent Congress trades in NVO

Company context for NVO

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. NVORegulatory notice·Federal Register

    Notice Pursuant to the National Cooperative Research and Production Act of 1993-R Consortium, Inc.

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Nov 10, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-11-09. Read the company report for its disclosures.

    Public: Nov 9, 2026, 8:09 AM ESTEvent / period: Nov 9, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-11-05. Read the company report for its disclosures.

    Public: Nov 5, 2026, 1:06 PM ESTEvent / period: Nov 5, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.